Jupiter Neurosciences Inc(JUNS) - 2024 Q3 - Quarterly Report

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the transition period from __________ to __________ JUPITER NEUROSCIENCES, INC. (Exact name of registrant as specified in its charter) Commission File Number: 001-41265 (State or other jurisdiction or incor ...